Stockreport

Incyte announces EU approval of Xencor-partnered lymphoma therapy [Seeking Alpha]

Xencor, Inc.  (XNCR) 
Last xencor, inc. earnings: 2/24 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.xencor.com/investor-relations
PDF its Xencor ( XNCR )-partnered antibody drug Minjuvi as a late-line option for certain adults with follicular lymphoma, a blood cancer. Accordingly, the treatment, also [Read more]